Phoenix Asia Holdings terminates deal to acquire ACEA Pharma
PHOE•Phoenix Asia Holdings terminated its planned acquisition of ACEA Pharma on November 3, 2026, after missing the November 2 closing deadline. No shares were issued, target equity transferred or acquisition consideration paid.
1. Deal terminated
Phoenix Asia Holdings terminated its planned acquisition of ACEA Pharma on November 3, 2026, after the deal missed its November 2 closing deadline. Under the May 4 agreement, ACEA Therapeutics would have received 100 million newly issued ordinary shares for all target equity; no termination fee applies, and each party generally bears its own costs.
